Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Hari Pujar
Introduction
Hari Pujar is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of immunology through his innovative work on polysaccharide-protein conjugates. His research focuses on enhancing the immunogenicity of these conjugates, which play a crucial role in vaccine development.
Latest Patents
Hari Pujar holds 1 patent for his invention titled "Enhancing immunogenicity of polysaccharide-protein conjugates." This patent presents immunogenic compositions that include one or more polysaccharide-protein conjugates. These conjugates consist of polysaccharides derived from bacterial capsules that are conjugated to a carrier protein in an aprotic solvent, such as dimethylsulfoxide (DMSO). The invention also outlines methods for enhancing the immune response to a pneumococcal polysaccharide protein conjugate vaccine by administering an immunogenic composition prepared under DMSO conditions.
Career Highlights
Hari Pujar is currently employed at Merck Sharp & Dohme Corporation, a leading pharmaceutical company known for its commitment to research and development in healthcare. His work at Merck has allowed him to contribute to advancements in vaccine technology and immunology.
Collaborations
Throughout his career, Hari has collaborated with esteemed colleagues, including Jian He and John E. MacNair. These collaborations have fostered a productive environment for innovation and research in the field of immunology.
Conclusion
Hari Pujar's contributions to the field of immunology through his patent on polysaccharide-protein conjugates exemplify the importance of innovation in vaccine development. His work continues to impact the healthcare industry positively.